HealthEquity, Inc. (NASDAQ:HQY) – Investment analysts at Barrington Research lifted their FY2022 earnings estimates for shares of HealthEquity in a research report issued on Tuesday, June 8th. Barrington Research analyst A. Paris. Jr now forecasts that the company will post earnings per share of $0.94 for the year, up from their previous forecast of $0.86. Barrington Research also issued estimates for HealthEquity’s Q4 2022 earnings at $0.25 EPS.
HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Sunday, June 6th. The company reported $0.38 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.32 by $0.06. HealthEquity had a return on equity of 6.49% and a net margin of 0.60%.
Shares of NASDAQ HQY opened at $77.98 on Thursday. The company has a current ratio of 2.25, a quick ratio of 2.25 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $6.50 billion, a P/E ratio of 649.83, a PEG ratio of 7.49 and a beta of 1.36. The business’s fifty day moving average is $75.12. HealthEquity has a 1-year low of $45.82 and a 1-year high of $93.32.
Institutional investors have recently modified their holdings of the stock. Captrust Financial Advisors grew its stake in HealthEquity by 20.8% during the first quarter. Captrust Financial Advisors now owns 1,364 shares of the company’s stock worth $93,000 after buying an additional 235 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in shares of HealthEquity by 40.2% during the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,676 shares of the company’s stock valued at $187,000 after acquiring an additional 767 shares in the last quarter. Cigna Investments Inc. New acquired a new position in shares of HealthEquity during the 1st quarter valued at $201,000. Concorde Asset Management LLC purchased a new stake in HealthEquity during the 1st quarter worth $223,000. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in HealthEquity in the 4th quarter valued at $231,000. Hedge funds and other institutional investors own 98.08% of the company’s stock.
In related news, insider Darcy G. Mott sold 6,000 shares of the stock in a transaction dated Tuesday, April 20th. The stock was sold at an average price of $70.31, for a total transaction of $421,860.00. Following the transaction, the insider now directly owns 77,052 shares in the company, valued at $5,417,526.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 18,000 shares of company stock worth $1,315,080 in the last 90 days. Insiders own 2.80% of the company’s stock.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.